Kynurenine and quinolinic acid, tryptophan metabolites produced by IDO activation, are known to possess potentially detrimental properties for the nervous system, as they enhance oxidative stress and neuronal apoptosis and potentiate anxiety- and depression-like behavior in animal models and in humans [282,283]. This evidence concerns the gene IDO1 and depressive disorder.